These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

567 related articles for article (PubMed ID: 33568752)

  • 1. Advanced glycation end products (AGEs) and other adducts in aging-related diseases and alcohol-mediated tissue injury.
    Rungratanawanich W; Qu Y; Wang X; Essa MM; Song BJ
    Exp Mol Med; 2021 Feb; 53(2):168-188. PubMed ID: 33568752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced glycation end products and their receptor in age-related, non-communicable chronic inflammatory diseases; Overview of clinical evidence and potential contributions to disease.
    Reynaert NL; Gopal P; Rutten EPA; Wouters EFM; Schalkwijk CG
    Int J Biochem Cell Biol; 2016 Dec; 81(Pt B):403-418. PubMed ID: 27373680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative Stress and Advanced Lipoxidation and Glycation End Products (ALEs and AGEs) in Aging and Age-Related Diseases.
    Moldogazieva NT; Mokhosoev IM; Mel'nikova TI; Porozov YB; Terentiev AA
    Oxid Med Cell Longev; 2019; 2019():3085756. PubMed ID: 31485289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assay for advanced glycation end products generating intracellular oxidative stress through binding to its receptor.
    Kobori T; Ganesh D; Kumano-Kuramochi M; Torigoe K; Machida S
    Anal Biochem; 2020 Dec; 611():114018. PubMed ID: 33186591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Glyoxalase in Glycation and Carbonyl Stress Induced Metabolic Disorders.
    Saeed M; Kausar MA; Singh R; Siddiqui AJ; Akhter A
    Curr Protein Pept Sci; 2020; 21(9):846-859. PubMed ID: 32368974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does accumulation of advanced glycation end products contribute to the aging phenotype?
    Semba RD; Nicklett EJ; Ferrucci L
    J Gerontol A Biol Sci Med Sci; 2010 Sep; 65(9):963-75. PubMed ID: 20478906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implication of advanced glycation end products (Ages) and their receptor (Rage) on myocardial contractile and mitochondrial functions.
    Neviere R; Yu Y; Wang L; Tessier F; Boulanger E
    Glycoconj J; 2016 Aug; 33(4):607-17. PubMed ID: 27277623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced glycation end products (AGEs) and their involvement in liver disease.
    Hyogo H; Yamagishi S
    Curr Pharm Des; 2008; 14(10):969-72. PubMed ID: 18473847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Advanced Glycation End Products (AGEs) Accumulation by Pyridoxamine Modulates Glomerular and Mesangial Cell Estrogen Receptor α Expression in Aged Female Mice.
    Pereira-Simon S; Rubio GA; Xia X; Cai W; Choi R; Striker GE; Elliot SJ
    PLoS One; 2016; 11(7):e0159666. PubMed ID: 27428057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathological Role of Advanced Glycation End Products (AGEs) and their Receptor Axis in Atrial Fibrillation.
    Yamagishi SI; Sotokawauchi A; Matsui T
    Mini Rev Med Chem; 2019; 19(13):1040-1048. PubMed ID: 30854960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced glycation end products (AGEs) and cardiovascular dysfunction: focus on high molecular weight AGEs.
    Deluyker D; Evens L; Bito V
    Amino Acids; 2017 Sep; 49(9):1535-1541. PubMed ID: 28710551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic deficiency of neuronal RAGE protects against AGE-induced synaptic injury.
    Zhang H; Wang Y; Yan S; Du F; Wu L; Yan S; Yan SS
    Cell Death Dis; 2014 Jun; 5(6):e1288. PubMed ID: 24922072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Role for Advanced Glycation End Products in Molecular Ageing.
    Zgutka K; Tkacz M; Tomasiak P; Tarnowski M
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allicin Alleviates Diabetes Mellitus by Inhibiting the Formation of Advanced Glycation End Products.
    Li L; Song Q; Zhang X; Yan Y; Wang X
    Molecules; 2022 Dec; 27(24):. PubMed ID: 36557926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of advanced glycation end products in diabetic vascular injury: molecular mechanisms and therapeutic perspectives.
    Liu J; Pan S; Wang X; Liu Z; Zhang Y
    Eur J Med Res; 2023 Dec; 28(1):553. PubMed ID: 38042909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced Glycation End Products: A Molecular Target for Vascular Complications in Diabetes.
    Yamagishi S; Nakamura N; Suematsu M; Kaseda K; Matsui T
    Mol Med; 2015 Oct; 21 Suppl 1(Suppl 1):S32-40. PubMed ID: 26605646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA-aptamers raised against AGEs as a blocker of various aging-related disorders.
    Yamagishi S; Taguchi K; Fukami K
    Glycoconj J; 2016 Aug; 33(4):683-90. PubMed ID: 27338620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of AGEs in aging: causation or correlation.
    Baynes JW
    Exp Gerontol; 2001 Sep; 36(9):1527-37. PubMed ID: 11525875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Advanced Glycation End Products in Carcinogenesis and their Therapeutic Implications.
    Schröter D; Höhn A
    Curr Pharm Des; 2018; 24(44):5245-5251. PubMed ID: 30706806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phytochemicals Against Advanced Glycation End Products (AGEs) and the Receptor System.
    Yamagishi SI; Matsui T; Ishibashi Y; Isami F; Abe Y; Sakaguchi T; Higashimoto Y
    Curr Pharm Des; 2017; 23(8):1135-1141. PubMed ID: 27774900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.